NEW YORK (GenomeWeb News) – Nanoparticle characterization company NanoSight today announced it has been acquired by Malvern Instruments for an undisclosed amount.

The deal was completed on Sept. 27.

UK-based NanoSight has developed a technology dubbed Nanoparticle Tracking Analysis, or NTA, and said that its instruments and software enable the rapid and simultaneous multiparameter analysis and characterization of different nanoscale particles.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.